Thromboembolism Early After Glucocorticoid Administration in Patients with Autoimmune Hemolytic Anemia [0.03%]
自身免疫性溶血性贫血患者接受糖皮质激素治疗早期的血栓栓塞事件
Kohei Shiroshita,Mikio Okayama,Hiroki Soma et al.
Kohei Shiroshita et al.
Pulmonary embolism and deep venous thrombosis (PE/DVT) are well-known lethal complications in autoimmune hemolytic anemia (AIHA). However, the impact of their treatment is unclear. Here, we describe three elderly Japanese patients with AIHA...
Clinical and Cytogenetic Characterization, and Outcome of Chronic Lymphocytic Leukemia Patients in a Single Tertiary Center in Saudi Arabia [0.03%]
沙特阿拉伯单中心慢性淋巴细胞白血病患者的临床和细胞遗传学特征及预后分析
Areej Al Mugairi,Ekremah Alzarea,Abdulaziz Almosa et al.
Areej Al Mugairi et al.
Refractory Anaplastic Large Cell Lymphoma Rescued by the Combination of the Second-Generation ALK Inhibitor Brigatinib, High-dose Chemotherapy and Allogeneic Stem Cell Transplantation: A Case Report and Review of the Literature [0.03%]
布加替尼联合大剂量化疗及异基因造血干细胞移植治疗难治性间变性大细胞淋巴瘤1例及文献复习
Giulia Caddeo,Cristina Tecchio,Matteo Chinello et al.
Giulia Caddeo et al.
The treatment of pediatric patients with refractory or relapsed anaplastic large cell lymphoma (ALCL) is still a major challenge. In addition to conventional chemotherapy and stem cell transplantation, new therapeutic options such as anti-C...
Venetoclax: A New Partner in the Novel Treatment Era for Acute Myeloid Leukemia and Myelodysplastic Syndrome [0.03%]
维奈托克在急性髓系白血病和骨髓增生异常综合征新型治疗时代的应用伙伴疗法作用机制及研究进展
Jean El-Cheikh,Ghassan Bidaoui,Mustafa Saleh et al.
Jean El-Cheikh et al.
Background: Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) are two closely related blood cancers that are more frequent in older adults. AML is the most common type of adult acute leukemia, and MDS is cha...
Current Advances in Multiple Myeloma: A Post International Myeloma Society (IMS 2022) Round Table Debate by the International Academy for Clinical Hematology (IACH) [0.03%]
国际血液学临床学院(IMS 2022研讨会后 round table 辩论)关于多发性骨髓瘤的最新进展
Nizar J Bahlis,Luciano J Costa,Thierry Facon et al.
Nizar J Bahlis et al.
This round table discussion organized by the International Academy for Clinical Hematology (IACH) was dedicated to the 19th annual meeting of the International Myeloma Society (IMS), which was held in Los Angeles between the 25th and 27th A...
CD34 Stem Cell Boost in Pediatric Allogeneic Stem Cell Transplant Recipients: A Case Series and Review of Literature [0.03%]
儿科同种异体干细胞移植受者的CD34干细胞增强：病例系列和文献回顾
Sara Bowman,Joe Stanek,Rajinder Bajwa et al.
Sara Bowman et al.
Patients with poor graft function (PGF) or declining donor chimerism (DC) post allogeneic hematopoietic cell transplantation (HCT) may benefit from a CD34-selected stem cell boost (SCB). We retrospectively studied outcomes of fourteen pedia...
Safety of CAR-T Cell Therapy in Patients With Renal Failure/Acute Kidney Injury: Focused Review [0.03%]
CAR-T细胞治疗在肾衰竭/急性肾脏损伤患者中的安全性：综述性文章
Israr Khan,Nida Khan,Natalie Wolfson et al.
Israr Khan et al.
Chimeric antigen receptor (CAR) T-cell therapy is novel immunotherapy targeting specifically cancerous cells, and has been shown to induce durable remissions in some refractory hematological malignancies. However, CAR T-cell therapy has adv...
Mohamad Mohty,Junia V Melo
Mohamad Mohty
Mohamad Mohty,Giampaolo Merlini
Mohamad Mohty
Outcome of Stem Cell Transplantation in HTLV-1-Associated North American Adult T-Cell Leukemia/Lymphoma [0.03%]
人类T淋巴细胞病毒Ⅰ型感染的成人T细胞白血病/淋巴瘤自体造血干细胞移植预后因素分析及影响生存的因素探究（北美地区）
Abdul-Hamid Bazarbachi,Daniel Reef,Hiba Narvel et al.
Abdul-Hamid Bazarbachi et al.
Adult T-cell leukemia/lymphoma (ATLL) remains challenging to treat and has dismal outcome. Allogeneic stem-cell transplantation (allo-SCT) has promising results, but data remain scarce. In this single-center retrospective analysis of 100 pa...